{"transactions":[{"id":724977,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-29T20:07:27.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":26000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001218815-26-000002","document":"form4-06292026_080622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000121881526000002/form4-06292026_080622.xml","form_type":"4"}},{"id":1119004,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-09T20:08:36.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-25-016219","document":"form4-06092025_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016219/form4-06092025_080631.xml","form_type":"4"}},{"id":1478170,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-17T20:03:51.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-24-017140","document":"form4-06172024_080647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017140/form4-06172024_080647.xml","form_type":"4"}},{"id":1749493,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-11-03T20:49:48.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":437244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on November 1, 2023. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":437244,"derivative":{"exercise_price":0.2088,"expiration_date":"2033-11-01","underlying":"Common Stock","underlying_shares":437244},"source":{"system":"sec-edgar","filing":"0001493152-23-039336","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315223039336/ownership.xml","form_type":"4"}},{"id":1850841,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-20T20:08:31.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":11300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":11300,"derivative":{"exercise_price":36.87,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":11300},"source":{"system":"sec-edgar","filing":"0001415889-23-010034","document":"form4-06202023_080626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588923010034/form4-06202023_080626.xml","form_type":"4"}},{"id":2114314,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-11-17T02:34:37.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":142657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on November 14, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":142657,"derivative":{"exercise_price":0.7268,"expiration_date":"2032-11-14","underlying":"Common Stock","underlying_shares":142657},"source":{"system":"sec-edgar","filing":"0001493152-22-032692","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315222032692/ownership.xml","form_type":"4"}},{"id":2214200,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-05T22:00:12.000Z","date":"2022-06-22","kind":"gift","acquired":true,"shares":1358122,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees"},"balance_after":4694566,"source":{"system":"sec-edgar","filing":"0001493152-22-018581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315222018581/ownership.xml","form_type":"4"}},{"id":2214199,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-05T22:00:12.000Z","date":"2022-06-22","kind":"gift","acquired":false,"shares":1358122,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert Conrad 2020 Grantor Retained Annuity Trust (GRAT)"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-22-018581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315222018581/ownership.xml","form_type":"4"}},{"id":2214198,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-05T22:00:12.000Z","date":"2021-08-04","kind":"gift","acquired":true,"shares":494622,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees"},"balance_after":3336444,"source":{"system":"sec-edgar","filing":"0001493152-22-018581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315222018581/ownership.xml","form_type":"4"}},{"id":2214197,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-05T22:00:12.000Z","date":"2021-08-04","kind":"gift","acquired":false,"shares":494622,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-22-018581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315222018581/ownership.xml","form_type":"4"}},{"id":2229174,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-17T20:08:27.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":13600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":13600,"derivative":{"exercise_price":22.48,"exercise_date":"2023-06-16","expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":13600},"source":{"system":"sec-edgar","filing":"0001415889-22-006705","document":"form4-06172022_010604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922006705/form4-06172022_010604.xml","form_type":"4"}},{"id":2528394,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-02T20:17:01.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":90882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2021. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":90882,"derivative":{"exercise_price":1.12,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":90882},"source":{"system":"sec-edgar","filing":"0001493152-21-026989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315221026989/ownership.xml","form_type":"4"}},{"id":2636874,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-07-09T21:30:14.000Z","date":"2021-07-07","kind":"gift","acquired":true,"shares":1280917,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees"},"balance_after":2841822,"source":{"system":"sec-edgar","filing":"0001493152-21-016565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315221016565/ownership.xml","form_type":"4"}},{"id":2636873,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-07-09T21:30:14.000Z","date":"2021-07-07","kind":"gift","acquired":false,"shares":1280917,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert Conrad 2020 Grantor Retained Annuity Trust (GRAT)"},"balance_after":1358122,"source":{"system":"sec-edgar","filing":"0001493152-21-016565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315221016565/ownership.xml","form_type":"4"}},{"id":2655682,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-06-24T21:37:54.000Z","date":"2021-06-19","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the \"Certificate\") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the \"Certificate\") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0.5,"exercise_date":"2018-06-21","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000905718-21-000824","document":"matinasbio_fm4jun192021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571821000824/matinasbio_fm4jun192021.xml","form_type":"4"}},{"id":2655681,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-06-24T21:37:54.000Z","date":"2021-06-19","kind":"exercise","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the \"Certificate\") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date."}],"balance_after":1560905,"source":{"system":"sec-edgar","filing":"0000905718-21-000824","document":"matinasbio_fm4jun192021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571821000824/matinasbio_fm4jun192021.xml","form_type":"4"}},{"id":2655680,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-06-24T21:37:54.000Z","date":"2021-06-19","kind":"other","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock dividend, payable to all holders of record of Series B Preferred Stock of 400 shares of Common Stock for each share of Series B Preferred Stock."}],"balance_after":1360905,"source":{"system":"sec-edgar","filing":"0000905718-21-000824","document":"matinasbio_fm4jun192021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571821000824/matinasbio_fm4jun192021.xml","form_type":"4"}},{"id":2662441,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-21T20:19:38.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":12000,"derivative":{"exercise_price":28,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-21-006888","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021006888/edgar.xml","form_type":"4"}},{"id":2698484,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-05-24T21:30:18.000Z","date":"2021-01-13","kind":"gift","acquired":true,"shares":100,"price":1000,"value":100000.0,"ownership":{"direct":false,"nature":"By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."}],"balance_after":100,"derivative":{"exercise_price":0.5,"exercise_date":"2018-06-21","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-21-012764","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315221012764/ownership.xml","form_type":"4"}},{"id":2698483,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-05-24T21:30:18.000Z","date":"2021-01-13","kind":"gift","acquired":false,"shares":100,"price":1000,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0.5,"exercise_date":"2018-06-21","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-21-012764","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315221012764/ownership.xml","form_type":"4"}},{"id":2698482,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-05-24T21:30:18.000Z","date":"2021-05-20","kind":"gift","acquired":true,"shares":1145905,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees"},"balance_after":1320905,"source":{"system":"sec-edgar","filing":"0001493152-21-012764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315221012764/ownership.xml","form_type":"4"}},{"id":2698481,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-05-24T21:30:18.000Z","date":"2021-05-20","kind":"gift","acquired":false,"shares":1145905,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert Conrad 2019 Grantor Retained Annuity Trust (GRAT)"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-21-012764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315221012764/ownership.xml","form_type":"4"}},{"id":2698480,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-05-24T21:30:18.000Z","date":"2021-01-13","kind":"gift","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees"},"balance_after":175000,"source":{"system":"sec-edgar","filing":"0001493152-21-012764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315221012764/ownership.xml","form_type":"4"}},{"id":2698479,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-05-24T21:30:18.000Z","date":"2021-01-13","kind":"gift","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":494622,"source":{"system":"sec-edgar","filing":"0001493152-21-012764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315221012764/ownership.xml","form_type":"4"}},{"id":2986215,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-11-10T21:05:39.000Z","date":"2020-11-02","kind":"grant","acquired":true,"shares":122605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2020. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":122605,"derivative":{"exercise_price":0.82,"expiration_date":"2030-11-02","underlying":"Common Stock","underlying_shares":122605},"source":{"system":"sec-edgar","filing":"0001493152-20-020921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315220020921/ownership.xml","form_type":"4"}},{"id":3100710,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-06-25T01:00:29.000Z","date":"2020-06-23","kind":"other","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock dividend, payable to all holders of record of Series B Preferred Stock of 300 shares of Common Stock for each share of Series B Preferred Stock."}],"balance_after":544622,"source":{"system":"sec-edgar","filing":"0001493152-20-011764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315220011764/ownership.xml","form_type":"4"}},{"id":3104877,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-19T12:03:38.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."}],"balance_after":11000,"derivative":{"exercise_price":10.38,"exercise_date":"2021-06-18","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001179110-20-007587","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020007587/edgar.xml","form_type":"4"}},{"id":3120066,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-06-05T20:10:29.000Z","date":"2020-06-04","kind":"gift","acquired":true,"shares":2639039,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert Conrad 2020 Grantor Retained Annuity Trust (GRAT)"},"balance_after":2639039,"source":{"system":"sec-edgar","filing":"0001493152-20-010651","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315220010651/ownership.xml","form_type":"4"}},{"id":3120065,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-06-05T20:10:29.000Z","date":"2020-06-04","kind":"gift","acquired":false,"shares":2639039,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad and Judith Conrad, Trustees"},"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001493152-20-010651","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315220010651/ownership.xml","form_type":"4"}},{"id":3146934,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-05-15T20:01:03.000Z","date":"2020-05-13","kind":"gift","acquired":true,"shares":2639039,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad and Judith Conrad, Trustees"},"balance_after":2764039,"source":{"system":"sec-edgar","filing":"0001493152-20-009089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315220009089/ownership.xml","form_type":"4"}},{"id":3146933,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-05-15T20:01:03.000Z","date":"2020-05-13","kind":"gift","acquired":false,"shares":2639039,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Herbert Conrad 2019 Grantor Retained Annuity Trust (GRAT)"},"balance_after":1145905,"source":{"system":"sec-edgar","filing":"0001493152-20-009089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315220009089/ownership.xml","form_type":"4"}},{"id":3322172,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-01-03T21:05:56.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":10573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 31, 2019, the Reporting Person was issued 10,573 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Incentive Plan. Such shares vest immediately upon grant."}],"balance_after":514622,"source":{"system":"sec-edgar","filing":"0001493152-20-000123","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315220000123/ownership.xml","form_type":"4"}},{"id":3379954,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-11-05T21:05:12.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":107416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2019. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":107416,"derivative":{"exercise_price":0.912,"expiration_date":"2029-11-01","underlying":"Common Stock","underlying_shares":107416},"source":{"system":"sec-edgar","filing":"0001493152-19-016456","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315219016456/ownership.xml","form_type":"4"}},{"id":3400583,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-10-02T22:13:45.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Converts automatically into Common Stock upon the earlier of (i) notice by the Issuer to the holders that the Issuer elected to convert all outstanding shares of Class A Preferred, (ii) July 29, 2019, (iii) the approval of the Issuer's MAT2203 product candidate by the U.S. Food and Drug Administration or the European Medicines Agency (the \"Regulatory Approval\") or (iv) the Regulatory Approval of the Issuer's MAT2501 product candidate."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2016-07-29","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-19-014915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315219014915/ownership.xml","form_type":"4"}},{"id":3400582,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-10-02T22:13:45.000Z","date":"2016-07-29","kind":"purchase","acquired":true,"shares":20000,"price":5,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Converts automatically into Common Stock upon the earlier of (i) notice by the Issuer to the holders that the Issuer elected to convert all outstanding shares of Class A Preferred, (ii) July 29, 2019, (iii) the approval of the Issuer's MAT2203 product candidate by the U.S. Food and Drug Administration or the European Medicines Agency (the \"Regulatory Approval\") or (iv) the Regulatory Approval of the Issuer's MAT2501 product candidate."}],"balance_after":20000,"derivative":{"exercise_price":0,"exercise_date":"2016-07-29","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-19-014915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315219014915/ownership.xml","form_type":"4"}},{"id":3400581,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-10-02T22:13:45.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":38066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On September 30, 2019, the Reporting Person was issued 38,066 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":504049,"source":{"system":"sec-edgar","filing":"0001493152-19-014915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315219014915/ownership.xml","form_type":"4"}},{"id":3400580,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-10-02T22:13:45.000Z","date":"2019-06-21","kind":"other","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock dividend, payable to all holders of record of Series B Preferred Stock of 200 shares of Common Stock for each share of Series B Preferred Stock."}],"balance_after":465983,"source":{"system":"sec-edgar","filing":"0001493152-19-014915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315219014915/ownership.xml","form_type":"4"}},{"id":3400579,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-10-02T22:13:45.000Z","date":"2019-07-26","kind":"other","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock dividend, payable to all holders of record of Series A Preferred Stock of 2.4 shares of Common Stock for each share of Series A Preferred Stock."}],"balance_after":445983,"source":{"system":"sec-edgar","filing":"0001493152-19-014915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315219014915/ownership.xml","form_type":"4"}},{"id":3400578,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-10-02T22:13:45.000Z","date":"2019-07-26","kind":"exercise","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":397983,"source":{"system":"sec-edgar","filing":"0001493152-19-014915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315219014915/ownership.xml","form_type":"4"}},{"id":3470666,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-07-02T22:38:36.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":28005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 30, 2019, the Reporting Person was issued 28,005 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":197983,"source":{"system":"sec-edgar","filing":"0001493152-19-010196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315219010196/ownership.xml","form_type":"4"}},{"id":3483510,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-06-20T20:26:31.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."}],"balance_after":4500,"derivative":{"exercise_price":2.78,"exercise_date":"2020-06-19","expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001179110-19-007969","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911019007969/edgar.xml","form_type":"4"}},{"id":3518128,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-05-20T22:38:49.000Z","date":"2019-05-16","kind":"purchase","acquired":true,"shares":25000,"price":0.9646,"value":24115.0,"ownership":{"direct":false,"nature":"By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad and Judith Conrad, Trustees"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.9563 to $0.9650, inclusive. Upon request of the SEC staff, the reporting person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":172959,"source":{"system":"sec-edgar","filing":"0001493152-19-007947","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000149315219007947/ownership.xml","form_type":"4"}},{"id":3564125,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-03T20:45:26.000Z","date":"2019-03-31","kind":"grant","acquired":true,"shares":22019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 31, 2019, the Reporting Person was issued 22,019 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":122019,"source":{"system":"sec-edgar","filing":"0000905718-19-000327","document":"conrad_fm4feb82019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571819000327/conrad_fm4feb82019.xml","form_type":"4"}},{"id":3662637,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-12T22:39:31.000Z","date":"2019-02-08","kind":"gift","acquired":false,"shares":3932903,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0000905718-19-000106","document":"conrad_fm4feb82019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571819000106/conrad_fm4feb82019.xml","form_type":"4"}},{"id":3703422,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T21:02:03.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":40337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 31, 2018, the Reporting Person was issued 40,337 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":4032903,"source":{"system":"sec-edgar","filing":"0000905718-19-000020","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571819000020/ownership.xml","form_type":"4"}},{"id":3774000,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-11-05T13:17:46.000Z","date":"2018-11-01","kind":"grant","acquired":true,"shares":128299,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":128299,"derivative":{"exercise_price":0.74,"exercise_date":"2018-11-01","expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":128299},"source":{"system":"sec-edgar","filing":"0000905718-18-000909","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571818000909/ownership.xml","form_type":"4"}},{"id":3773999,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-11-05T13:17:46.000Z","date":"2018-11-01","kind":"grant","acquired":true,"shares":128299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":128299,"derivative":{"exercise_price":0.74,"expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":128299},"source":{"system":"sec-edgar","filing":"0000905718-18-000909","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571818000909/ownership.xml","form_type":"4"}},{"id":3798181,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-03T20:25:35.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":26087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 1, 2018, the Reporting Person was granted 26,087 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equit Compensation Plan. Such shares vest immediately upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 1, 2018, the Reporting Person was granted 26,087 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equit Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":3992566,"source":{"system":"sec-edgar","filing":"0000905718-18-000817","document":"conrad-matinas_fm4jun212018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571818000817/conrad-matinas_fm4jun212018.xml","form_type":"4"}},{"id":3869162,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-11T20:44:35.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":55300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 29, 2018, the Reporting Person was granted 55,300 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan.  Such shares vest immediately upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 29, 2018, the Reporting Person was granted 55,300 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan.  Such shares vest immediately upon grant."}],"balance_after":3966479,"source":{"system":"sec-edgar","filing":"0000905718-18-000626","document":"conrad-matinas_fm4jun292018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571818000626/conrad-matinas_fm4jun292018.xml","form_type":"4"}},{"id":3884992,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-06-22T23:30:17.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"derivative":{"exercise_price":6.75,"exercise_date":"2018-06-19","expiration_date":"2028-06-19","underlying":"Common Shares","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001140361-18-029668","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036118029668/doc1.xml","form_type":"4"}},{"id":3884782,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-06-22T20:20:52.000Z","date":"2018-06-21","kind":"purchase","acquired":true,"shares":100,"price":1000,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 21, 2018, the Reporting Person purchased 100 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On June 21, 2018, the Reporting Person purchased 100 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."}],"balance_after":100,"derivative":{"exercise_price":0.5,"exercise_date":"2018-06-21","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000905718-18-000582","document":"conrad-matinas_fm4jun212018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571818000582/conrad-matinas_fm4jun212018.xml","form_type":"4"}},{"id":3893263,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-15T11:30:18.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."}],"balance_after":67000,"derivative":{"exercise_price":0.6011,"exercise_date":"2019-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001179110-18-008559","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911018008559/edgar.xml","form_type":"4"}},{"id":3976098,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-02T21:09:23.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":31579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 30, 2018, the Reporting Person was issued 31,579 shares of common stock par value $.0001 per share which vest immediately upon grant."}],"balance_after":3911179,"source":{"system":"sec-edgar","filing":"0000905718-18-000359","document":"conradmatinas_fm4mar302018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571818000359/conradmatinas_fm4mar302018.xml","form_type":"4"}},{"id":4214569,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:06:58.000Z","date":"2017-09-07","kind":"purchase","acquired":true,"shares":100000,"price":1.3,"value":130000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.40, inclusive. The reporting person undertakes to provide Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":3879600,"source":{"system":"sec-edgar","filing":"0000905718-17-000825","document":"conrad_fm4sept72017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218815/000090571817000825/conrad_fm4sept72017.xml","form_type":"4"}},{"id":4274537,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option Grant (Right to Buy)","published_at":"2017-06-22T20:59:42.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"derivative":{"exercise_price":3.55,"exercise_date":"2017-06-21","expiration_date":"2027-06-21","underlying":"Common Shares","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001140361-17-025881","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036117025881/doc1.xml","form_type":"4"}},{"id":4280105,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-06-16T13:29:51.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Such option vests in three equal annual installments beginning June 15, 2018."}],"balance_after":15000,"derivative":{"exercise_price":2.32,"exercise_date":"2018-06-15","expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001179110-17-009166","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911017009166/edgar.xml","form_type":"4"}},{"id":4280104,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2017-06-16T13:29:51.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 15, 2017, the Company awarded 10,000 shares of Company common stock as an annual equity grant in the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option Plan subject to time-based forfeiture restrictions."}],"balance_after":38500,"source":{"system":"sec-edgar","filing":"0001179110-17-009166","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911017009166/edgar.xml","form_type":"4"}}]}